Literature DB >> 30257888

A Longitudinal Study of the Association of Clinical Indices of Cardiovascular Autonomic Function with Breast Cancer Treatment and Exercise Training.

Amy A Kirkham1, Matthew G Lloyd2, Victoria E Claydon2, Karen A Gelmon3, Donald C McKenzie3, Kristin L Campbell4.   

Abstract

BACKGROUND: Cardiovascular autonomic dysfunction is an early marker for cardiovascular disease. Anthracycline chemotherapy and left-sided radiation for breast cancer are associated with negative autonomic function changes. This study's objectives were to characterize changes in, and the association of exercise training with, clinical indices of cardiovascular autonomic function across the trajectory of breast cancer therapy. SUBJECTS, MATERIALS, AND METHODS: Seventy-three patients receiving adjuvant chemotherapy participated to varying degrees in supervised aerobic and resistance exercise during chemotherapy ± radiation and for 20 weeks after. Resting heart rate (HRrest) and blood pressure were measured weekly during chemotherapy. HRrest, exercise heart rate recovery (HRrecovery), and aerobic fitness were measured at enrollment, end of chemotherapy ± radiation, and 10 and 20 weeks after treatment.
RESULTS: During chemotherapy, HRrest increased in a parabolic manner within a single treatment and with increasing treatment dose, whereas systolic and diastolic blood pressure decreased linearly across treatments. Tachycardia and hypotension were present in 32%-51% of participants. Factors associated with weekly changes during chemotherapy included receiving anthracyclines or trastuzumab, days since last treatment, hematocrit, and exercise attendance. Receipt of anthracyclines, trastuzumab, and left-sided radiation individually predicted impairments of HRrest and HRrecovery during chemotherapy ± radiation; however, aerobic fitness change and at least twice-weekly exercise attendance predicted improvement. By 10 weeks after treatment, HRrest and blood pressure were not different from prechemotherapy.
CONCLUSION: In this study, chemotherapy resulted in increased HRrest and tachycardia, as well as decreased blood pressure and hypotension. Anthracyclines, trastuzumab, and left-sided radiation were associated with HRrest elevations and impairments of HRrecovery, but exercise training at least twice a week appeared to mitigate these changes. IMPLICATIONS FOR PRACTICE: This study characterized changes in clinically accessible measures with well-established prognostic value for cardiovascular disease, and investigated associations with cardiotoxic treatments and the positive influence of exercise. The chemotherapy-related incremental increase in resting heart rate, with tachycardia occurring in one third of patients, and decrease in blood pressure, with hypotension occurring in one half of the patients, is relevant to oncology practitioners for clinical examination or patient report of related symptoms (i.e., dizziness). The weekly dose of two 60-minute sessions of moderate-intensity aerobic and resistance exercise that was identified as protective of cardiovascular autonomic impairments can easily be prescribed to patients by oncologists. © AlphaMed Press 2018.

Entities:  

Keywords:  Blood pressure; Breast neoplasms; Exercise; Heart rate

Year:  2018        PMID: 30257888      PMCID: PMC6369953          DOI: 10.1634/theoncologist.2018-0049

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  25 in total

Review 1.  Exercise and autonomic function in health and cardiovascular disease.

Authors:  E T Rosenwinkel; D M Bloomfield; M A Arwady; R L Goldsmith
Journal:  Cardiol Clin       Date:  2001-08       Impact factor: 2.213

2.  Comparison of aerobic exercise intensity prescription methods in breast cancer.

Authors:  Amy A Kirkham; Kristin L Campbell; Donald C McKenzie
Journal:  Med Sci Sports Exerc       Date:  2013-08       Impact factor: 5.411

3.  Daily fatigue patterns and effect of exercise in women with breast cancer.

Authors:  A L Schwartz
Journal:  Cancer Pract       Date:  2000 Jan-Feb

4.  Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.

Authors:  Lee W Jones; Kerry S Courneya; John R Mackey; Hyman B Muss; Edith N Pituskin; Jessica M Scott; Whitney E Hornsby; April D Coan; James E Herndon; Pamela S Douglas; Mark Haykowsky
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

Review 5.  A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.

Authors:  Michael S Ewer; Stefan Glück
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

6.  Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.

Authors:  Paolo Palatini; Athanase Benetos; Guido Grassi; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Krzystof Narkiewicz; Gianfranco Parati; Achille C Pessina; Luis M Ruilope; Alberto Zanchetti
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

7.  Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women.

Authors:  M L Pollock; C Foster; D Schmidt; C Hellman; A C Linnerud; A Ward
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

Review 8.  Early breast cancer therapy and cardiovascular injury.

Authors:  Lee W Jones; Mark J Haykowsky; Jonas J Swartz; Pamela S Douglas; John R Mackey
Journal:  J Am Coll Cardiol       Date:  2007-09-24       Impact factor: 24.094

9.  Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer.

Authors:  Lee W Jones; Mark Haykowsky; Edith N Pituskin; Nick G Jendzjowsky; Corey R Tomczak; Robert G Haennel; John R Mackey
Journal:  Oncologist       Date:  2007-10

10.  Effectiveness of Oncologist-Referred Exercise and Healthy Eating Programming as a Part of Supportive Adjuvant Care for Early Breast Cancer.

Authors:  Amy A Kirkham; Cheri L Van Patten; Karen A Gelmon; Donald C McKenzie; Alis Bonsignore; Kelcey A Bland; Kristin L Campbell
Journal:  Oncologist       Date:  2017-10-05
View more
  12 in total

1.  Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study.

Authors:  Kyuwan Lee; Irene Kang; Wendy J Mack; Joanne Mortimer; Fred Sattler; George Salem; Janice Lu; Christina M Dieli-Conwright
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

Review 2.  The Beneficial Role of Physical Exercise on Anthracyclines Induced Cardiotoxicity in Breast Cancer Patients.

Authors:  Eliana Tranchita; Arianna Murri; Elisa Grazioli; Claudia Cerulli; Gian Pietro Emerenziani; Roberta Ceci; Daniela Caporossi; Ivan Dimauro; Attilio Parisi
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

3.  Approaches to management of cardiovascular morbidity in adult cancer patients - cross-sectional survey among cardio-oncology experts.

Authors:  E Hedayati; A Papakonstantinou; A Månsson-Broberg; J Bergh; L Hubbert; R Altena
Journal:  Cardiooncology       Date:  2020-09-01

4.  Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial.

Authors:  Kyuwan Lee; Irene Kang; Wendy J Mack; Joanne Mortimer; Fred Sattler; George Salem; Christina M Dieli-Conwright
Journal:  BMC Cancer       Date:  2019-07-03       Impact factor: 4.430

5.  Criteria for the determination of maximal oxygen uptake in patients newly diagnosed with cancer: Baseline data from the randomized controlled trial of physical training and cancer (Phys-Can).

Authors:  Ann Christin Helgesen Bjørke; Truls Raastad; Sveinung Berntsen
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

Review 6.  Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.

Authors:  Dong-Woo Kang; Rebekah L Wilson; Cami N Christopher; Amber J Normann; Oscar Barnes; Jordan D Lesansee; Gyuhwan Choi; Christina M Dieli-Conwright
Journal:  Front Cardiovasc Med       Date:  2022-01-14

7.  Time-Dependent Effect of Anthracycline-Based Chemotherapy on Central Arterial Stiffness: A Systematic Review and Meta-Analysis.

Authors:  Caroline Schneider; Nathalia González-Jaramillo; Thimo Marcin; Kristin L Campbell; Thomas Suter; Arjola Bano; Matthias Wilhelm; Prisca Eser
Journal:  Front Cardiovasc Med       Date:  2022-07-05

Review 8.  Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.

Authors:  Michael G Fradley; Theresa M Beckie; Sherry Ann Brown; Richard K Cheng; Susan F Dent; Anju Nohria; Kristen K Patton; Jagmeet P Singh; Brian Olshansky
Journal:  Circulation       Date:  2021-06-17       Impact factor: 29.690

9.  A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study.

Authors:  Filadelfiya Zvinovski; Julie A Stephens; Bhuvaneswari Ramaswamy; Raquel E Reinbolt; Anne M Noonan; Jeffrey Bryan VanDeusen; Robert Wesolowski; Daniel G Stover; Nicole Olivia Williams; Sagar D Sardesai; Laxmi Mehta; Randi Foraker; Martha Gulati; Maryam Lustberg; Allison M Quick
Journal:  J Oncol       Date:  2021-05-27       Impact factor: 4.375

Review 10.  Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer.

Authors:  Renske Altena; Laila Hubbert; Narsis A Kiani; Yvonne Wengström; Jonas Bergh; Elham Hedayati
Journal:  Cardiooncology       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.